Maurizio Muscaritoli

Maurizio Muscaritoli's AcademicInfluence.com Rankings

Philosophy

#9633

World Rank

#13221

Historical Rank

Logic

#6602

World Rank

#8134

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Maurizio Muscaritoli's Degrees

PhD Medical Sciences Sapienza University of Rome
Doctorate Medicine Sapienza University of Rome

Why Is Maurizio Muscaritoli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Maurizio Muscaritoli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Definition and classification of cancer cachexia: an international consensus. (2011) (3613)
Cachexia: a new definition. (2008) (1968)
ESPEN guidelines on nutrition in cancer patients. (2017) (1659)
Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". (2010) (1410)
ESPEN guidelines on definitions and terminology of clinical nutrition. (2017) (1204)
Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. (2015) (1179)
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community. (2018) (872)
Sarcopenia with limited mobility: an international consensus. (2011) (848)
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. (2006) (819)
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. (2019) (744)
ESPEN expert group recommendations for action against cancer-related malnutrition. (2017) (616)
ESPEN guidelines on artificial enteral nutrition--percutaneous endoscopic gastrostomy (PEG). (2005) (583)
Nutritional recommendations for the management of sarcopenia. (2010) (564)
GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community* (2019) (431)
ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. (2009) (359)
Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself (2005) (302)
Sarcopenia: A Time for Action. An SCWD Position Paper (2019) (288)
Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. (2014) (283)
ESPEN guideline clinical nutrition in neurology. (2017) (252)
Prevention and treatment of cancer cachexia: new insights into an old problem. (2006) (238)
ESPEN practical guideline: Clinical Nutrition in cancer. (2021) (232)
Nutritional assessment and therapy in COPD: a European Respiratory Society statement (2014) (230)
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study (2017) (205)
Increased Muscle Proteasome Activity Correlates With Disease Severity in Gastric Cancer Patients (2003) (181)
Muscle myostatin signalling is enhanced in experimental cancer cachexia (2008) (174)
Increased muscle ubiquitin mRNA levels in gastric cancer patients. (2001) (163)
IGF-1 is downregulated in experimental cancer cachexia. (2006) (162)
Nutritional and metabolic support in patients undergoing bone marrow transplantation. (2002) (160)
Consensus on cachexia definitions. (2010) (143)
Cancer-induced muscle wasting: latest findings in prevention and treatment (2017) (135)
Evidence-based recommendations for addressing malnutrition in health care: an updated strategy from the feedM.E. Global Study Group. (2014) (124)
Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. (2004) (114)
Autophagy is induced in the skeletal muscle of cachectic cancer patients (2016) (112)
n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis (2012) (111)
Malnutrition in hemodialysis patients: what therapy? (2005) (110)
Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. (1992) (104)
Muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved? (2010) (103)
The Role for Dietary Omega-3 Fatty Acids Supplementation in Older Adults (2014) (96)
Plasma amino acid imbalance in patients with lung and breast cancer. (1995) (92)
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. (2002) (91)
Branched-chain amino acids: the best compromise to achieve anabolism? (2005) (88)
Glutamine as indispensable nutrient in oncology: experimental and clinical evidence (2010) (88)
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review (2019) (86)
Variables associated with reduced dietary intake in hemodialysis patients. (2005) (86)
The “parallel pathway”: a novel nutritional and metabolic approach to cancer patients (2011) (85)
Request for regulatory guidance for cancer cachexia intervention trials (2015) (85)
Duodenal Pathology and Clinical-Immunological Implications in Common Variable Immunodeficiency Patients (2003) (81)
Changes in Myostatin Signaling in Non-Weight-Losing Cancer Patients (2012) (78)
β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. (2011) (76)
Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. (2017) (72)
Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials (2013) (71)
Cachexia: a preventable comorbidity of cancer. A T.A.R.G.E.T. approach. (2015) (70)
Anorexia in Hemodialysis Patients: The Possible Role of Des-Acyl Ghrelin (2007) (68)
Malnutrition and wasting in renal disease (2009) (67)
Mini-Nutritional Assessment, Malnutrition Universal Screening Tool, and Nutrition Risk Screening Tool for the Nutritional Evaluation of Older Nursing Home Residents. (2016) (67)
Plasma tryptophan and anorexia in human cancer. (1986) (66)
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. (2005) (63)
ω‐3 Fatty‐Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta‐Analysis and Trial Sequential Analysis (2019) (63)
Effectiveness and efficacy of nutritional therapy: A systematic review following Cochrane methodology. (2017) (63)
Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. (1998) (61)
Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? (2017) (60)
Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting (2015) (59)
Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. (2012) (56)
Are antioxidants useful for treating skeletal muscle atrophy? (2009) (55)
Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib. (2007) (55)
Novel therapeutic options for cachexia and sarcopenia (2016) (54)
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function. (2019) (51)
Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks (2012) (51)
Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib. (2008) (50)
Tumor-induced changes in host metabolism: a possible marker of neoplastic disease. (1995) (50)
Anorexia and serum leptin levels in hemodialysis patients. (2003) (49)
The early cancer anorexia paradigm: changes in plasma free tryptophan and feeding indexes. (1992) (49)
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy. (2019) (49)
Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. (1991) (49)
Perspectives of health care professionals on cancer cachexia: results from three global surveys (2016) (48)
Mechanism of early tumor anorexia. (1996) (47)
From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients (2019) (47)
Correction: n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis (2012) (47)
Therapy of muscle wasting in cancer: what is the future? (2004) (46)
Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation. (1994) (46)
The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects (2005) (46)
Albumin synthesis is diminished in men consuming a predominantly vegetarian diet. (2000) (45)
Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial (2017) (44)
Serum tumour necrosis factor‐α levels in cancer patients are discontinuous and correlate with weight loss (2000) (43)
Plasma and CSF tryptophan in cancer anorexia (2005) (42)
Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia? (2013) (41)
β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy. (2012) (41)
Nutritional Care in a Nursing Home in Italy (2013) (39)
Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. (2003) (38)
Interference with Ca2+-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia (2017) (36)
Increased plasma free tryptophan levels in human cancer: a tumor related effect? (1991) (36)
Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines (2018) (35)
Ghrelin: from discovery to cancer cachexia therapy (2014) (35)
Antimyopathic effects of carnitine and nicotine (2006) (33)
Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. (1986) (33)
Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity. (1997) (32)
Cancer cachexia: from molecular mechanisms to patient's care. (2012) (31)
Nutrition education in medical schools (NEMS). An ESPEN position paper. (2019) (31)
Summary of Proceedings and Expert Consensus Statements From the International Summit "Lipids in Parenteral Nutrition". (2020) (31)
Vitamin D and VDR in cancer cachexia and muscle regeneration (2017) (30)
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition. (2022) (29)
Parenteral nutrition in advanced cancer patients. (2012) (29)
Early changes of muscle insulin‐like growth factor‐1 and myostatin gene expression in gastric cancer patients (2013) (29)
Tumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease. (2003) (28)
Exogenous lipid clearance in compensated liver cirrhosis. (1986) (27)
Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. (2014) (27)
MuRF‐1 and p‐GSK3β expression in muscle atrophy of cirrhosis (2013) (27)
Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa (2019) (27)
Anorexia and Serum Leptin Levels in Hemodialysis Patients (2004) (27)
Nutritional care routines in Italy: results from the PIMAI (Project: Iatrogenic MAlnutrition in Italy) study (2010) (26)
The Impact of Nutrients on Mental Health and Well-Being: Insights From the Literature (2021) (25)
The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer (2016) (25)
Prognostic Factors of Renal Involvement in Systemic Sclerosis (2018) (24)
Biochemical indices may not accurately reflect changes in nutritional status after allogeneic bone marrow transplantation. (1995) (24)
Effects of simvastatin administration in an experimental model of cancer cachexia. (2003) (24)
Effect of intensive nutritional counseling and support on clinical outcomes of hemodialysis patients. (2012) (24)
EFFECTIVENESS AND COST-EFFECTIVENESS OF SUPPLEMENTAL GLUTAMINE DIPEPTIDE IN TOTAL PARENTERAL NUTRITION THERAPY FOR CRITICALLY ILL PATIENTS: A DISCRETE EVENT SIMULATION MODEL BASED ON ITALIAN DATA (2012) (23)
Cancer anorexia: new pathogenic and therapeutic insights. (1996) (23)
Amino acids and hepatic encephalopathy (1987) (22)
Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia (2005) (22)
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis (2021) (22)
Plasma amino acid concentrations in patients with acute myelogenous leukemia. (1999) (22)
Interventions to promote energy balance and cancer survivorship (2013) (22)
Effect of personalized dietary intervention on nutritional, metabolic and vascular indices in patients with chronic kidney disease. (2015) (22)
New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'. (2008) (22)
An Italian investigation on nutritional risk at hospital admission: The PIMAI (Project: Iatrogenic MAlnutrition in Italy) study (2009) (21)
Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib. (2005) (21)
Lipid Use in Hospitalized Adults Requiring Parenteral Nutrition. (2020) (20)
Plasma clearance of exogenous lipids in patients with malignant disease. (1990) (20)
Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects. (1991) (19)
Nutritional and metabolic derangements in Mediterranean cancer patients and survivors: the ECPC 2016 survey (2019) (19)
Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion (2018) (18)
Sarcopenia in critically ill patients: the new pandemia. (2013) (18)
Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss. (2006) (18)
Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C. (2003) (18)
Serotoninergic block in the ventromedial nucleus of hypothalamus improves food intake in anorectic tumor bearing rats. (1996) (18)
Muscle ubiquitin m-rNA levels in patients with end-stage renal disease on maintenance hemodialysis. (2002) (17)
Uptake of Amino Acids by Brain Micro vessels Isolated from Rats with Experimental Chronic Renal Failure (1988) (17)
The Domains of Human Nutrition: The Importance of Nutrition Education in Academia and Medical Schools (2017) (17)
Peripherally injected IL-1 induces anorexia and increases brain tryptophan concentrations. (1999) (17)
Impaired nutritional status in common variable immunodeficiency patients correlates with reduced levels of serum IgA and of circulating CD4+ T lymphocytes (2001) (17)
Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients (2014) (16)
What Are the Risk Factors for Malnutrition in Older-Aged Institutionalized Adults? (2020) (16)
Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis (2020) (16)
Abnormal substrate metabolism and nutritional strategies in cancer management. (1991) (16)
A nationally representative survey of hospital malnutrition: the Italian PIMAI (Project: Iatrogenic MAlnutrition in Italy) study (2009) (15)
Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients (2020) (15)
Current uses of total parenteral nutrition. (1993) (15)
Pain and Frailty in Hospitalized Older Adults (2020) (15)
Goals in Nutrition Science 2020-2025 (2021) (15)
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study (2019) (15)
The role of vitamin D in cancer cachexia (2017) (15)
Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging mice (2020) (15)
Switch from bicarbonate hemodialysis to hemodiafiltration with online regeneration of the ultrafiltrate (HFR): effects on nutritional status, microinflammation, and beta-microglobulin. (2005) (15)
The Three Faces of Sarcopenia. (2016) (14)
Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials (2019) (14)
A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review (2021) (14)
The metabolite beta-aminoisobutyric acid and physical inactivity among hemodialysis patients. (2017) (14)
Metabolic Reprogramming Promotes Myogenesis During Aging (2019) (14)
Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients (2017) (14)
Nutrition education in medical schools (NEMS). An ESPEN position paper. (2020) (14)
Nutrition support for treating cancer-associated weight loss: an update (2018) (13)
Safety and Tolerability of Targeted Medical Nutrition for Cachexia in Non-Small-Cell Lung Cancer: A Randomized, Double-Blind, Controlled Pilot Trial (2020) (13)
Left ventricular mass correlates with lean body mass in patients with disease-associated wasting (2014) (13)
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
Awareness of Cancer-Related Malnutrition and Its Management: Analysis of the Results From a Survey Conducted Among Medical Oncologists (2021) (12)
The hunger hormone ghrelin in cachexia (2013) (12)
The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem? (2021) (12)
Metabolic effects of glutamine on insulin sensitivity (2010) (11)
Malnutrition: the hidden killer in healthcare systems (2013) (11)
Assessing Malnutrition in Systemic Sclerosis With Global Leadership Initiative on Malnutrition and European Society of Clinical Nutrition and Metabolism Criteria (2020) (10)
Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia (2008) (10)
Economy matters to fight against malnutrition: Results from a multicenter survey. (2017) (10)
Plasma Amino-acids in Human Cancer: the Individual Role of Tumour, Malnutrition and Glucose Tolerance - (1988) (10)
VMN HYPOTHALAMIC DOPAMINE AND SEROTONIN IN ANORECTIC SEPTIC RATS (2000) (10)
Densitometry-based equations for estimating body composition in Fischer rats. (1993) (10)
Is des-acyl ghrelin contributing to uremic anorexia? (2007) (10)
Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study (2021) (10)
Interactions between dietary supplements in hospitalized patients (2016) (10)
The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies (2020) (10)
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition. (2022) (9)
Unifying diagnostic criteria for cachexia: An urgent need. (2017) (9)
α-lipoic acid in patients with autosomal dominant polycystic kidney disease. (2019) (9)
Metabolic and Clinical Effects of the Supplementation of a Functional Mixture of Amino Acids in Cerebral Hemorrhage (2011) (9)
Fluid intake and nutritional risk in non-critically ill patients at hospital referral (2010) (9)
Foods and their components promoting gastrointestinal cancer (2016) (9)
Angiogenic factors as prognostic markers in neuroendocrine neoplasms (2022) (8)
Pharmacoeconomics of Parenteral Nutrition with ω-3 Fatty Acids in Hospitalized Adults. (2020) (8)
Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload (2009) (8)
nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis (2019) (8)
Phase angle could be a marker of microvascular damage in systemic sclerosis. (2020) (8)
Autonomic dysfunction in kidney diseases. (2020) (8)
CaMKII activity is reduced in skeletal muscle during sepsis (2013) (7)
Nutritional management of stroke patients (2004) (7)
THE BASIS FOR A RATIONAL NUTRITIONAL APPROACH TO PATIENTS WITH CANCER (1999) (7)
Dynamics of central venous catheter-related sepsis in rats (1993) (7)
Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters (2020) (7)
Longitudinal Physical Activity Change During Hemodialysis and Its Association With Body Composition and Plasma BAIBA Levels (2019) (7)
Cancer cachexia: towards integrated therapeutic interventions (2014) (7)
The Ubiquitin/Proteasome System in Cancer Cachexia (2006) (6)
[Energy metabolism in cancer patients]. (1997) (6)
Muscle depletion and the prediction of chemotherapy toxicity (2013) (6)
Anorexia assessment in patients with cancer: a crucial issue to improve the outcome. (2015) (6)
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study (2021) (6)
Modifications of fasting glucose values as first sign of resistance in chronic myeloid leukemia chronic phase patients during imatinib treatment. (2010) (6)
Targeting cancer cachexia: we're on the way. (2016) (6)
Nutrition education in medical schools (NEMS) project: Joining ESPEN and university point of view. (2021) (6)
Does leptin contribute to uraemic cachexia? (2006) (5)
Tryptophan and secondary anorexia. (1996) (5)
Evaluation of Browning Markers in Subcutaneous Adipose Tissue of Newly Diagnosed Gastrointestinal Cancer Patients with and without Cachexia (2022) (5)
Cost‐Effectiveness of Parenteral Nutrition Containing ω‐3 Fatty Acids in Hospitalized Adult Patients From 5 European Countries and the US (2020) (5)
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. (2019) (5)
Idiopathic AL amyloidosis and biclonal paraproteinemia: A case report and review of the literature (2001) (5)
Effect of exogenous triglyceride infusion on the plasma amino-acid profile in liver cirrhosis (1988) (4)
DHA Oral Supplementation Modulates Serum Epoxydocosapentaenoic Acid (EDP) Levels in Breast Cancer Patients (2019) (4)
Statins, coenzyme Q10, and cachexia: what's the link? (2007) (4)
Carnitine for the treatment of cachexia: Lights and shadows. (2015) (4)
1450PEuropean survey of 907 people with cancer about the importance of nutrition (2017) (4)
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
Peptidic and Nonpeptidic Growth Hormone Secretagogues exert a protective effect on mitochondrial parameters analysed in a rat model of cachexia (2016) (4)
Insulin signaling and tight glucose control: a genetic link? (2010) (4)
A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection. (2021) (3)
Association Between Metabolic and Hormonal Derangements and Professional Exposure to Urban Pollution in a High Intensity Traffic Area (2020) (3)
Muscle performance and adenine-nucleotides status in MCA-sarcoma tumor-bearing rats (1992) (3)
PD-1/PD-L1 expression and regorafenib clinical efficacy on refractory pancreatic cancer patient. (2016) (3)
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia (2021) (3)
Plasma and CSF tryptophan in patients with cancer anorexia (1986) (3)
Cardiovascular risk and quality of life in autosomal dominant polycystic kidney disease patients in therapy with tolvaptan: A pilot study. (2020) (3)
Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function (2017) (3)
Nutritional and metabolic support in patients undergoing bone marrow transplantation 1 , 2 (3)
O.17 Effects of oral glutamine on high-dosechemotherapy (HDCT)-induced gastrointestinal toxicity in acute leukemia patients: a pilot study (1995) (3)
Effect of cisplatin and paclitaxel on plasma free tryptophan levels. An in vitro study. (1999) (3)
Effects of oral branched-chain amino acids (BCAA) administration in the treatment of cancer anorexia (1994) (3)
Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs (2021) (3)
Cerebro-Spinal Fluid Amino Acid Pattern in Hepatic Encephalopathy (1984) (3)
Patient access to oral nutritional supplements: Which policies count? (2019) (3)
Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients (2020) (3)
PLASMA-FREE AMINO-ACID ALTERATIONS OCCUR EARLY DURING TUMOR-GROWTH (1994) (3)
Timing of antioxidant supplementation is critical in improving anorexia in an experimental model of cancer (2013) (3)
Towards improved awareness and earlier diagnosis of early onset colorectal neoplasms (2014) (3)
Assessing Malnutrition in Systemic Sclerosis With GLIM and ESPEN Criteria. (2020) (3)
Unliability of biochemical parameters in the nutritional assessment of patients undergoing allogeneic bone marrow transplantation (BMT) for leukemia (1990) (2)
COVID-19: Lessons on malnutrition, nutritional care and public health from the ESPEN-WHO Europe call for papers (2022) (2)
Cachexia and Sarcopenia (2012) (2)
Anorexia in hemodialysis patients: the role of ghrelin (2005) (2)
Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors (2022) (2)
Cortisol and the muscle-bone axis (2014) (2)
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) (2021) (2)
SUN-LB640: Omega-3 Fatty-Acid Enriched Parenteral Nutrition Regimens in Hospitalized Patients in EU5 Countries: A Pharmacoeconomic Analysis (2019) (2)
Safety and tolerability of a novel oral nutritional supplement in healthy volunteers. (2020) (2)
Phase angle in systemic sclerosis: a marker for pulmonary function and disease severity (2020) (2)
Effect of nutritional support with highly purified, whey proteins for malnutrition and sarcopenia in patients affected with stage II-III colorectal or breast cancer: A blind, placebo controlled, randomized clinical trial. (2018) (2)
Corrigendum: Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function (2017) (1)
BETA-HYDROXY-BETA-METHYLBUTYRATE: A NEW THERAPEUTIC TOOL TO COUNTERACT WEIGHT AND MUSCLE LOSS IN CANCER CACHEXIA? (2008) (1)
Targeted Medical Nutrition in Pre-Cachectic Patients with Non-Small-Cell Lung Cancer: A Subgroup Analysis (2020) (1)
Inflammation and Nutritional Risk: A Feature to Consider in Planned Oncologic Surgery (2009) (1)
[Pathogenetic and therapeutic aspects of secondary anorexia]. (2000) (1)
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients (2021) (1)
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
Skeletal muscle apoptosis in gastric cancer (2003) (1)
Sarcopenia and its therapeutic strategies in ICU. (2014) (1)
Novel therapeutic strategies to improve deranged metabolism in chronic diseases: the potential role of carnitine and nicotine (2012) (1)
Assessment of renal microcirculation in biopsy-proven tubulointerstitial nephritis in patients with and without glomerular disease: The role of resistive index. (2022) (1)
PP139 NUTRITIONAL CARE ROUTINES IN ITALY: RESULTS FROM THE PIMAI STUDY (2010) (1)
Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic Review (2021) (1)
MYOSTATIN EXPRESSION IS UPREGULATED IN CANCER CACHEXIA. (2005) (1)
MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis (1)
Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients. (2022) (1)
Nephroangiosclerosis not related to hypertension: A matter to resolve in the era of precision medicine. (2022) (1)
Fatigue in Patients on Chronic Hemodialysis: The Role of Indoleamine 2,3-Dioxygenase (IDO) Activity, Interleukin-6, and Muscularity (2023) (1)
Nutritional recommendations for the management of stroke patients (2004) (1)
Protein Kinases in the Pathogenesis of Muscle Wasting (2012) (1)
MUSCLE IGF-1 GENE EXPRESSION IS DOWNREGULATED IN EXPERIMENTAL CANCER CACHEXIA (2005) (1)
Plasma tryptophan (TRP) levels and anorexia in liver cirrhosis (1991) (1)
Omega-3 fatty acids in parenteral nutrition - A systematic review with network meta-analysis on clinical outcomes. (2023) (1)
Plasma tryptophan and anorexia in cancer patients (1984) (1)
Role of metabolic changes of adiposity in cancer (2021) (1)
Effectiveness and ef fi cacy of nutritional therapy e A cochrane systematic review (2016) (1)
EARLY CHANGES OF MUSCLE IGF-1 AND MYOSTATIN GENE EXPRESSION IN GASTRIC CANCER PATIENTS (1)
Anorexia and serum leptin levels in hemodialysis patterns. Commentary (2004) (1)
Home artificial nutrition: national guidelines of reference (2008) (1)
Clinical impact of whey protein and nutritional counseling in gastrointestinal cancer patients. (2018) (1)
Sarcopenia and markers of atherosclerosis and endothelial dysfunction: Preliminary results from an italian cohort of ckd patients (2018) (1)
Commentary on 'Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition'. (2022) (1)
EFFECT OF LITHIUM ADMINISTRATION ON MUSCLE AND BODY WEIGHT LOSS IN EXPERIMENTAL CANCER CACHEXIA (2008) (1)
Nutritional Support in Cancer Topic 26 Module 26 . 5 Nutrition in Prevention of Cancer (2009) (0)
PP171-MON COMPARISON OF THE PERFORMANCE OF DIFFERENT SCREENING TOOLS IN IDENTIFYING MALNUTRITION AND FUNCTIONAL IMPAIRMENT IN HOSPITALIZED PATIENTS (2013) (0)
SUN-PO123: Plasma BAIBA Levels in Hemodialysis and its Association with Body Composition and Physical Activity Change: A Longitudinal Study (2019) (0)
O035 MYOSTATIN-DEPENDENT PATHWAY IN LUNG AND GASTRIC CANCER PATIENTS (2009) (0)
LB017-MON UPDATE ON PHARMACOECONOMICS IN NUTRITION: PARENTERAL GLUTAMINE SUPPLEMENT IN INTENSIVE CARE UNIT PATIENTS (2013) (0)
SUN-PP147: Peritoneal Dialysis in Older Adults: Evaluation of Clinical, Nutritional, and Metabolic Outcomes (2015) (0)
SUN-PO183: Correlation Between Left Ventricular Mass and Fat Free Mass Index in Patients with Systemic Sclerosis without Cardiovascular Disease (2019) (0)
Metabolic and histomorphological changes of adipose tissue in cachexia (2023) (0)
Nutritional Support in Cancer (2007) (0)
MON-PO498: Phase Angle as a Marker of Microvascular Damage in Systemic Sclerosis (2019) (0)
Analysis of prognostic factors in COVID-19 hospitalized patients: an Italian single-center case-control study. (2023) (0)
OP006 CARDIAC MASS (CM) CORRELATES WITH LEAN BODY MASS (LBM) IN PATIENTS WITH DISEASE-ASSOCIATED WASTING. A PILOT STUDY (2012) (0)
PP147-SUN PRE-CACHEXIA AND CACHEXIA IN SURGICAL CANCER PATIENTS (2012) (0)
SUN-P012: The Association Between Phosphatase and Tensin Homologue (PTEN) Expression, Glucose Control and Calories Supplemented in Critically Ill Patients (2017) (0)
Assessment of Skeletal Muscle Micrornas And Small Non-Coding Rnas In Patients With Gastrointestinal (GI) Cancer (2023) (0)
Abstract P143: Assessment Of Biventricular And Aortic Function In Arterial Systemic Hypertension By Speckle Tracking Echocardiography (2021) (0)
Cancer and Disordered Eating Behavior: The Issue of Anorexia (2021) (0)
P221 Stability After Dilution of an Oral Crystalline L-Glutamine Preparation (2009) (0)
Anorexia in cancer patients: evaluation of hypothalamic dysfunction by functional magnetic resonance imaging (fMRI) and its association with inflammation, ghrelin and leptin (2015) (0)
Early impairment of food intake in patients newly diagnosed with cancer (2023) (0)
1536PCANCER CACHEXIA: PERSPECTIVES OF HEALTH CARE PROFESSIONALS. (2014) (0)
Modifications of eating behavior in type II diabetic patients receiving 5-hydroxy-tryptophan (5HTP) (1992) (0)
Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools - Perspectives from different actors. (2022) (0)
Correction to: Phase angle in systemic sclerosis: a marker for pulmonary function and disease severity (2020) (0)
Corrigendum: Metabolic Reprogramming Promotes Myogenesis During Aging (2021) (0)
Ethics and artificial nutrition (2004) (0)
PP228-MON VITAMIN D AND MUSCLE WASTING IN CANCER CACHEXIA (2011) (0)
A Low Daily Intake of Simple Sugars in the Diet Is Associated with Improved Liver Function in Cirrhotic Liver Transplant Candidates (2023) (0)
Nutritional and Metabolic Support in Haematological Malignancies and Haematopoietic Stem-cell Transplantation (2015) (0)
PT11.01: Association Between Growth and Differentiation Factor (GDF)-15 Serum Levels, Anorexia and Sarcopenia in Gastrointestinal and Lung Cancer Patients (2019) (0)
PP099-SUN: The Prevalence of Malnutrition in Oncology (The Premio Project). Preliminary Results (2014) (0)
Lipid Mobilising Factor in Cancer Cachexi (2006) (0)
The conundrum of pre-cachexia existence. (2014) (0)
Letter of the Chairman (2012) (0)
5-HYDROXYTRYPTOPHAN ADMINISTRATION AND ANOREXIA IN HYPERPHAGIC OVERWEIGTH PATIENTS (1987) (0)
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
Anorexia And Changes In Autonomic Nervous System Activity Among Patients With Cancer (2023) (0)
Sa1452 Impact of Weight Loss on Surgical Outcomes in Resectable Pancreatic Cancer Patients Undergoing Pancreaticoduodenectomy (PD) (2016) (0)
Phase angle, fat-free mass index and the risk of digital ulcers in patients with systemic sclerosis (2021) (0)
The myokine beta-aminoisobutyric acid and physical inactivity in hemodialysis patients (2016) (0)
SUN-LB277: What are the Health Care Professionals’ Perspectives on Cancer Cachexia? Results from Three Global Surveys (2016) (0)
Cancer anorexia: hypothalamic dysfunction and its association with inflammation and appetite-regulating peptides in lung cancer patients (2015) (0)
Pharmacological inhibition of the ubiquitin/proteasome ATP-dependent system does not prevent muscle wasting in experimental cancer cachexia (2006) (0)
Anti-catabolic neurohormonal blockade to improve skeletal muscle during disease (2017) (0)
Nutrition in Prevention of Cancer (2009) (0)
Plasma amino acid (AA) levels in lung (LC) and breast (BC) cancer (1990) (0)
[Metabolico-nutritional changes in the cancer patient]. (1989) (0)
Effects of proteasome inhibition in an experimental model of cancer cachexia (2007) (0)
Kidney dysfunction is associated with adverse outcomes in internal medicine COVID-19 hospitalized patients. (2023) (0)
Muscle-related mirnas and its relationship with circulating GDF-15 and FGF-21 levels in patients with cardiac cachexia (2021) (0)
Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials (2013) (0)
Modifications in markers of browning in white adipose tissue of patients with cancer cachexia (2021) (0)
MON-P082: Nutritional Status in Naïve Cancer Patients Affects Long-Term Outcome. A Compelling Need for Early Intervention (2016) (0)
OP007: Autophagy is Induced in the Skeletal Muscle in Human Cancer Cachexia (2014) (0)
The clinical and economic value of the dipeptide alanyl-glutamine in total parenteral nutrition of critically ill patients treated in intensive care units in Italy (2009) (0)
P.10.20 EVALUATION OF APPETITE AND FOOD INTAKE IN GASTROINTESTINAL CANCER PATIENTS AT FIRST ONCOLOGY VISIT (2018) (0)
PIH20 Cost-Effectiveness of Supplemental N-3 in Total Parenteral Nutrition Therapy in the Italian, French, German and UK Context: A Discrete Event Simulation Model (2012) (0)
OP046 DISEASE-SPECIFIC ENTERAL NUTRITION IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) (2011) (0)
SUN-PP013: Reimbursement Affects Prescription of Enteral and Parenteral Nutrition? Results from European Multicenter Survey (2015) (0)
SUN-P115: Older Adults with Reduced Renal Function: Evaluation of the Effects of Underlying Renal Disease on Nutritional and Metabolic Profile (2017) (0)
GDF-15, FGF-21 and myomirs in patients with gastrointestinal cancer (2020) (0)
Changes of gene expression in peripheral blood mononuclear cells of lung cancer patients with or without anorexia. (2022) (0)
Aspecific effect of arginine deprivation on in-vitro lymphocyte activation (1992) (0)
A new CV catheter can be safely replaced in 12 hrs after catheter removal for sepsis: a prospective rat study (1992) (0)
Effects of glucose-based and lipid-based TPN regimens in patients undergoing allogeneic bone marrow transplantation (A-BMT): preliminary results (1992) (0)
P.42 Increased brain tryptophan (TRP) concentrations may contribute to interleukin-1 (IL-1) induced anorexia (1998) (0)
Nutrition and Prevention of Diseases Topic 20 Module 20 . 3 Nutrition in the Prevention of Cancer (0)
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO) (2023) (0)
Nutritional and metabolic rehabilitation for long-term cancer survivors: give life the right weight (2013) (0)
Endocrinological and Nutritional Implications of Anorexia of Aging (2021) (0)
PP053-SUN THE PREVALENCE AND PROGNOSTIC VALUE OF PRE-CACHEXIA AND CACHEXIA AT DIAGNOSIS OF STAGE III NSCLC (2011) (0)
Intensive Nutritional Counselling And Support And Clinical Outcomes In Hemodialysis Patients (2012) (0)
SUN-P123: Beta-Aminoisobutyric Acid in Physical Inactivity Among Hemodialysis Patients (2016) (0)
Phase angle, nutritional status, and mortality in systemic sclerosis: An exploratory pilot study. (2022) (0)
Prevention and treatment of catheter-related venous thrombosis in long-term parenteral nutrition: A SINuC position statement (2023) (0)
Stability after dilution of an oral L-glutamine preparation (2010) (0)
PP088-SUN: Evaluation of Hypothalamic Activity in Cancer Anorexia by Functional Magnetic Resonance (2014) (0)
Role of vitamin D in the pathogenesis of muscle wasting in cancer cachexia (2013) (0)
Older adults with chronic kidney disease (CKD): Role of the multidimensional prognostic index (MPI) in patients on conservative and replacement therapy (2018) (0)
GM01: Comparison of ESPEN 2015 and GLIM Criteria for Assessing Malnutrition in Systemic Sclerosis (2019) (0)
PP041-MON: Functional Status is Reduced in Nursing Home Residents at Nutritional Risk (2014) (0)
The basis for a rational approach to patients with cancer (1999) (0)
T06.01.11 THE QUADRICEPS MUSCLE ULTRASOUND IN THE DIAGNOSIS OF SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS (2020) (0)
Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients (2013) (0)
PP198-SUN GLUTAMINE SUPPLEMENTATION AND BODY WEIGHT LOSS IN OBESE, NON-DIETING, NON-DIABETIC FEMALE PATIENTS: A PILOT STUDY (2011) (0)
Reply to A Molfino (2007) (0)
PP039-SUN AGREEMENT BETWEEN MNA, MUST AND NRS IN THE EVALUATION OF NUTRITIONAL RISK IN ELDERLY INSTITUTIONALISED SUBJECTS (2013) (0)
Association between BP and mortality in patients on chronic peritoneal dialysis (2006) (0)
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022. (2023) (0)
0.63 Plasma concentrations of taurine and otheramino acids in patients with acute leukemias (1995) (0)
PP172-SUN EFFECTIVENESS OF MULTIDISCIPLINARY DAY-HOSPITAL APPROACH TO ANOREXIA NERVOSA, BULIMIA NERVOSA AND BINGE EATING DISORDERS (2011) (0)
T06.01.18 EFFECTS OF BETA-HYDROXY-BETA-METHYLBUTYRATE SUPPLEMENTATION IN PATIENTS WITH LIVER CIRRHOSIS: A RANDOMIZED CONTROLLED PILOT STUDY (2020) (0)
Beta-aminoisobutyric acid as a biomarker of physical inactivity among hemodialysis patients. (2016) (0)
Preliminary results of the effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: a randomized controlled pilot study (2020) (0)
New Strategies for Metabolic Support in Cancer (2012) (0)
PP085 ENTERAL NUTRITION AND SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS (2010) (0)
Cancer-Associated Anorexia: Analysis Of Gene Expression In Peripheral Blood Mononuclear Cells (Pbmcs) Of Lung Cancer Patients (2023) (0)
Evaluation of clinical, nutritional, and metabolic outcomes in older vs younger peritoneal dialysis patients (2015) (0)
Brief Report Idiopathic AL amyloidosis and biclonal paraproteinemia: a case report the literature and review of (2001) (0)
A patient with severe anemia and body weight loss: unveiling what was behind (2021) (0)
Comparative effects of arginine and other amino acid deprivation on in vitro expression of lymphocyte activation markers. (1994) (0)
loss during palliative systemic (Tx) predicts time to progression (TTP) in (2018) (0)
Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action. (2023) (0)
PLASMA-FREE TRYPTOPHAN IN PATIENTS WITH CANCER (1994) (0)
SUN-PO071: Effects Of Oral DHA Supplementation in Modulating Serum Epoxydocosapentaenoic Acid Levels in Breast Cancer Patients (2019) (0)
P143 THE GERIATRIC NUTRITIONAL RISK INDEX AS SCREENING TOOL AT HOSPITAL ADMISSION: A COMPARISON WITH THE NRS-2002 IN PATIENTS AGED OVER 70 YEARS OLD (2009) (0)
P144 FLUID INTAKE AND NUTRITIONAL RISK AT HOSPITAL REFERRAL (2009) (0)
Editorial: Muscle mass and function in COVID-19 (2022) (0)
The relevance of nutritional and metabolic derangements in COVID-19 patients (2021) (0)
MON-PO499: Fat Free Mass is Reduced in Female Systemic Sclerosis Patients and Correlates with Disease Variables (2019) (0)
Reduction of glycosilated haemoglobin with sta- ble plasma insulin level in a ph+ cml diabetic patient responsive to imatinib (2005) (0)
MON-P232: Weight Loss and Surgical Outcomes in Patients Undergoing Pancreaticoduodenectomy (PD) for Pancreatic Cancer (2016) (0)
OR018: Cancer Anorexia: Assessment of Hypothalamic Dysfunction by Functional Magnetic Resonance Imaging (FMRI) and Its Association with Inflammation, Ghrelin, and Leptin in Lung Cancer Patients (2015) (0)
Abstracts of the 8th International Symposium Amino Acid/Protein Metabolism in Health and Disease (2014) (0)
Left Ventricular Mass Index As Potential Surrogate of Muscularity in Patients With Systemic Sclerosis Without Cardiovascular Disease. (2020) (0)
Brain serotonin and the control of food intake under physiological and pathological conditions (2012) (0)
Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis (2022) (0)
Short-term changes in nutritional status, energy expenditure, dietary intake in patients undergoing liver transplantation (2007) (0)
Gastrointestinal involvement and low muscularity in systemic sclerosis (2020) (0)
nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis (2019) (0)
A 36-year-old man, body builder presenting with unexpected severe anemia (2023) (0)
Brain Dysfunction in Respiratory Failure (1984) (0)
Body composition and microvascular damage in systemic sclerosis patients (2020) (0)
P151 MUSCLE SERINE PROTEASES ACTIVITY IN EXPERIMENTAL CANCER CACHEXIA (2008) (0)
An Unusual Complication of Transthoracic Lung Biopsy (2014) (0)
PP091-MON BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) IMPROVES GLUCOCORTICOID-INDUCED MUSCLE WASTING IN CULTURED MYOTUBES (2012) (0)
P214 NUTRITIONAL COUNSELLING AND NUTRITIONAL SUPPORT POSITIVELY AFFECTS CLINICAL OUTCOME OF HAEMODIALYSIS PATIENTS (2008) (0)
Effect of beta-hydroxy-beta-methylbutyrate on weight and muscle loss in cancer cachexia (2007) (0)
SUN-P068: Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on Plasma DHA Levels and Omega-3 Index in Breast Cancer (BC) Patients (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Maurizio Muscaritoli?

Maurizio Muscaritoli is affiliated with the following schools:

Sapienza University of Rome